SEOM clinical guidelines for the treatment of head and neck cancer (2017)
Clin. transl. oncol. (Print)
; Clin. transl. oncol. (Print);20(1): 75-83, ene. 2018. tab, ilus
Article
en En
| IBECS
| ID: ibc-170470
Biblioteca responsable:
ES1.1
Ubicación: BNCS
ABSTRACT
Head and neck cancer (HNC) is defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence obtained since 2013 publication, Spanish Society of Medical Oncology (SEOM) presents an update of HNC diagnosis and treatment guideline. The eighth edition of TNM classification, published in January 2017, introduces important changes for p16-positive oropharyngeal tumours, for lip and oral cavity cancer and for N3 category. In addition, there are new data about induction chemotherapy and the role of immunotherapy in HNC (AU)
RESUMEN
No disponible
Texto completo:
1
Colección:
06-national
/
ES
Base de datos:
IBECS
Asunto principal:
Neoplasias Orofaríngeas
/
Quimioterapia de Inducción
/
Neoplasias de Cabeza y Cuello
Tipo de estudio:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Clin. transl. oncol. (Print)
Año:
2018
Tipo del documento:
Article